| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |